Based on its own performance, itchi sales in 2020 were 22.6 billion won, a 47.6% increase from the previous year (15 billion won).
Itchi is a toothpaste-type gum treatment launched in 2011, and it contains three herbal ingredients: chamomile, ratany, and myrrh with excellent antibacterial and anti-inflammatory properties.
It is a method of brushing the gums by squeezing the contents of the tube like toothpaste, so even people who are burdened with taking gum medicine can easily manage their gums and teeth.
It is continuing its growth based on the new concept of high convenience, compliance, and management of harmful bacteria in the oral cavity.
Itchi, which recorded 3.7 billion won in sales in the year of its launch, exceeded 10 billion won in 2014, four years after its launch, and sold about 3.23 million units in 2020, exceeding 20 billion won in sales.
According to data from IQVIA, Gitchi occupies 94% of the market share of toothpaste-type gum treatments, and the number of sales of pharmaceutical gums is also ranked first.
An official of Dong Wha Pharm said, “Itchi, which opened a new paradigm of’gum treatment while wiping,’ focused on improving consumer convenience in the existing oral drug-centered gum treatment market, surpassed 20 billion won in sales in 10 years after launch. “Thanks to consumers,” he said, “We plan to consistently introduce its brand tailored to various age groups and customer preferences.”
Meanwhile, Dong Wha Pharm released’Itch Paste Phytoncide’ in February of last year, which added cypress phytoncide to it. Phytoncide refers to an antibacterial substance made by forest plants. The phytoncide component extracted from cypress trees is known to inhibit oral harmful bacteria and have a bad breath inhibitory effect.